Literature DB >> 23953776

Molecular mechanisms of HPV induced carcinogenesis in head and neck.

Theodoros Rampias1, Clarence Sasaki1, Amanda Psyrri2.   

Abstract

A growing subgroup of oropharyngeal cancers is initiated by infection with high-risk human papillomaviruses (HPVs). In parallel to mounting epidemiological evidence, solid experimental data support a causal association between HPV and a subset of oropharyngeal cancers. This Review summarizes the main events of the HPV life cycle, the functions of the viral oncoproteins, and the implications of HPV infection on their hosts, with an emphasis on carcinogenic mechanisms in oropharyngeal cancer. The demonstration that HPVs have a role in head and neck carcinogenesis has fuelled the expectation that HPV-targeted therapeutic strategies may prove curative in these cancers.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HPV; Notch; Oropharynx cancer; Tumor suppressor pathways; Wnt

Mesh:

Year:  2013        PMID: 23953776     DOI: 10.1016/j.oraloncology.2013.07.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  24 in total

1.  Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology.

Authors:  T de Perrot; V Lenoir; M Domingo Ayllón; N Dulguerov; M Pusztaszeri; M Becker
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

Review 2.  Second-generation prophylactic HPV vaccines: successes and challenges.

Authors:  Mitchell Tyler; Ebenezer Tumban; Bryce Chackerian
Journal:  Expert Rev Vaccines       Date:  2013-12-18       Impact factor: 5.217

Review 3.  Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis.

Authors:  Trinath Das; Rong Zhong; Michael T Spiotto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.

Authors:  Sebastian Blatt; Nadine Voelxen; Keyvan Sagheb; Andreas Max Pabst; Stefan Walenta; Thies Schroeder; Wolfgang Mueller-Klieser; Thomas Ziebart
Journal:  Clin Oral Investig       Date:  2016-01-04       Impact factor: 3.573

5.  A TGF-β1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer.

Authors:  Ye Tao; Erich M Sturgis; Zhigang Huang; Yan Sun; Kristina R Dahlstrom; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2018-05-02       Impact factor: 7.396

Review 6.  Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.

Authors:  Robbie Woods; Esther M O'Regan; Susan Kennedy; Cara Martin; John J O'Leary; Conrad Timon
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

Review 7.  Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.

Authors:  Shanthi Marur; Barbara Burtness
Journal:  Curr Opin Oncol       Date:  2014-05       Impact factor: 3.645

8.  Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.

Authors:  Toni M Brand; Stefan Hartmann; Neil E Bhola; Hua Li; Yan Zeng; Rachel A O'Keefe; Max V Ranall; Sourav Bandyopadhyay; Margaret Soucheray; Nevan J Krogan; Carolyn Kemp; Umamaheswar Duvvuri; Theresa LaVallee; Daniel E Johnson; Michelle A Ozbun; Julie E Bauman; Jennifer R Grandis
Journal:  Cancer Res       Date:  2018-02-12       Impact factor: 13.312

Review 9.  Current trends in the etiology and diagnosis of HPV-related head and neck cancers.

Authors:  Ryan C Chai; Duncan Lambie; Mukesh Verma; Chamindie Punyadeera
Journal:  Cancer Med       Date:  2015-02-01       Impact factor: 4.452

10.  In North America, some ovarian cancers express the oncogenes of preventable human papillomavirus HPV-18.

Authors:  Patrick Roos; Paul A Orlando; Richard M Fagerstrom; John W Pepper
Journal:  Sci Rep       Date:  2015-02-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.